THC-Based Treatment Shows Promise in Reducing PTSD Nightmares

A recent study found that a drug composed of THC, the primary psychoactive compound in cannabis, lowered both the severity and frequency of nightmares in individuals diagnosed with post‑traumatic stress disorder (PTSD). Nightmares are a common and debilitating symptom of PTSD, often exacerbating anxiety and sleep disruption. Current pharmacological options for nightmare relief are limited, and many patients report inadequate relief. The findings suggest that THC may offer a novel therapeutic avenue, potentially improving sleep quality and overall well-being for those suffering from PTSD. Further research will be needed to confirm efficacy, determine optimal dosing, and assess long‑term safety.